Vericel Corporation

Healthcare · Biotechnology · United States

Last price 40.26 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.06B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use devic...